Evidence map›Paper›PMID 20859824›Full record

ReviewJournal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews2010

Review of chromium (VI) apoptosis, cell-cycle-arrest, and carcinogenesis.

A Chiu, X L Shi, W K P Lee, R Hill, T P Wakeman, A Katz, B Xu, N S Dalal, J D Robertson, C Chen and 2 more

Abstract readReview
In one paragraph

Review in Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 3 countries.

A ChiuNational Center for Environmental Assessment DC, US Environmental Protection Agency, Washington, DC 20460, USA. Chiu.Arthur@epa.gov
X L Shi
W K P Lee
R Hill
T P Wakeman
A Katz
B Xu
N S Dalal
J D Robertson
C Chen
N Chiu
L Donehower
Dalhousie University · CAEnvironmental Protection Agency · USBaylor College of Medicine · USDuke University · USEnvironmental Protection Agency · IEIllinois State University · USNational High Magnetic Field Laboratory · USUniversity of Alabama at Birmingham Hospital · USUniversity of Kansas Medical Center · USUniversity of Kentucky · US

Funding

Oxidative Stress in Cr(VI)-induced CarcinogenesisR01CA116697 · NCI · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN · 2007 to 2011
$1.4M
NCI NIH HHS 1R01CA116697NCI NIH HHS R01 CA116697
6 · The paper itself

Abstract

Hexavalent chromium combines with glutathione in chloride intracellular channel carrier to form tetravalent and pentavalent chromium in plasma and organelle membranes. It also combines with NADH/NADPH to form pentavalent chromium in mitochondria. Tetravalent- and pentavalent- chromium (directly and indirectly) mediated DNA double strand breaks activate DNA damage signaling sensors: DNA-dependent-protein-kinase signals p53-dependent intrinsic mitochondrial apoptosis, and ataxia-telangiectasia-mutated and ataxia-telangiectasia-Rad3-related signal cell-arrest for DNA repair. Tetravalent chromium may be the most potent species since it causes DNA breaks and somatic recombination, but not apoptosis. Upon further failure of apoptosis and senescence/DNA-repair, damaged cells may become immortal with loss-of-heterozygosity and genetic plasticity.

Indexed as

ApoptosisCell CycleCell Transformation, NeoplasticChromiumHumansChromium

Identifiers

PMID20859824
PMCPMC4330561
OpenAlexW2009159361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.